Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Mato AR, Roeker LE, Lamanna N, Allan JN, Leslie L, Pagel JM, Patel K, Osterborg A, Wojenski D, Kamdar M, Huntington SF, Davids MS, Brown JR, Antic D, Jacobs R, Ahn IE, Pu J, Isaac KM, Barr PM, Ujjani CS, Geyer MB, Berman E, Zelenetz AD, Malakhov N, Furman RR, Koropsak M, Bailey N, Hanson L, Perini GF, Ma S, Ryan CE, Wiestner A, Portell CA, Shadman M, Chong EA, Brander DM, Sundaram S, Seddon AN, Seymour E, Patel M, Martinez-Calle N, Munir T, Walewska R, Broom A, Walter H, El-Sharkawi D, Parry H, Wilson MR, Patten PEM, Hernández-Rivas JÁ, Miras F, Fernández Escalada N, Ghione P, Nabhan C, Lebowitz S, Bhavsar E, López-Jiménez J, Naya D, Garcia-Marco JA, Skånland SS, Cordoba R, Eyre TA. Mato AR, et al. Among authors: chong ea. Blood. 2020 Sep 3;136(10):1134-1143. doi: 10.1182/blood.2020006965. Blood. 2020. PMID: 32688395 Free PMC article. Clinical Trial.
Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies.
Mato A, Fuchs BD, Heitjan DF, Mick R, Halpern SD, Shah PD, Jacobs S, Olson EM, Schuster SJ, Ujjani C, Chong EA, Loren AW, Miltiades AN, Luger S. Mato A, et al. Among authors: chong ea. Cancer Biol Ther. 2009 Jun;8(12):1095-1100. doi: 10.4161/cbt.8.12.8528. Cancer Biol Ther. 2009. PMID: 19652524
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.
Schuster SJ, Svoboda J, Chong EA, Nasta SD, Mato AR, Anak Ö, Brogdon JL, Pruteanu-Malinici I, Bhoj V, Landsburg D, Wasik M, Levine BL, Lacey SF, Melenhorst JJ, Porter DL, June CH. Schuster SJ, et al. Among authors: chong ea. N Engl J Med. 2017 Dec 28;377(26):2545-2554. doi: 10.1056/NEJMoa1708566. Epub 2017 Dec 10. N Engl J Med. 2017. PMID: 29226764 Free PMC article. Clinical Trial.
CAR T cell viability release testing and clinical outcomes: is there a lower limit?
Chong EA, Levine BL, Grupp SA, Davis MM, Siegel DL, Maude SL, Gladney WL, Frey NV, Porter DL, Hwang WT, Chong ER, June CH, Schuster SJ. Chong EA, et al. Among authors: chong er. Blood. 2019 Nov 21;134(21):1873-1875. doi: 10.1182/blood.2019002258. Blood. 2019. PMID: 31554634 Free PMC article. No abstract available.
Ibrutinib-associated Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes.
Rhodes JM, LoRe VA 3rd, Mato AR, Chong EA, Barrientos JC, Gerson JN, Barta SK, Landsburg DJ, Nasta SD, Svoboda J, Loren AW, Schuster SJ. Rhodes JM, et al. Among authors: chong ea. Clin Lymphoma Myeloma Leuk. 2020 Jul;20(7):438-444.e1. doi: 10.1016/j.clml.2020.02.001. Epub 2020 Feb 27. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32197990 Free PMC article.
56 results